Cue Biopharma Inc
F:1UC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cue Biopharma Inc
F:1UC
|
US |
|
M
|
Meta Platforms Inc
XHAM:FB2A
|
US |
|
Sherwin-Williams Co
NYSE:SHW
|
US |
|
Serco Group PLC
LSE:SRP
|
UK |
|
Holmen AB
F:HL9C
|
SE |
Wall St Price Targets
1UC Price Targets Summary
Cue Biopharma Inc
According to Wall Street analysts, the average 1-year price target for
1UC is 3.44 EUR with a low forecast of 3.41 EUR and a high forecast of 3.54 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1UC's stock price target?
Price Target
3.44
EUR
According to Wall Street analysts, the average 1-year price target for
1UC is 3.44 EUR with a low forecast of 3.41 EUR and a high forecast of 3.54 EUR.
What is the Revenue forecast for Cue Biopharma Inc?
Projected CAGR
17%
The compound annual growth rate for Revenue over the next 8 years is 17%.